Taurine
Amino AcidAlso known as: 2-aminoethanesulfonic acid
Taurine is a sulfur-containing compound abundant in muscle, heart, retina, and brain. Unlike most amino acids, it is not incorporated into proteins but plays broad roles in osmoregulation, membrane stabilization, calcium homeostasis, bile acid conjugation, and antioxidant defense. Research interest has historically focused on cardiovascular health and exercise performance. A landmark 2023 paper in Science (Singh et al.) elevated interest in taurine's potential role in aging biology, finding that taurine declines with age and that supplementation extended lifespan in mice — an exciting finding that awaits human interventional replication.
Evidence Summary
All 3 studiesTaurine (2-aminoethanesulfonic acid) is a sulfur-containing compound found at high concentrations in the heart, skeletal muscle, retina, and brain. Despite being categorized as an amino acid, it is not incorporated into proteins — it functions instead in osmoregulation, modulation of calcium homeostasis, membrane stabilization, conjugation of bile acids, and antioxidant defense. The human body can synthesize taurine from methionine and cysteine, but dietary sources (primarily meat and seafood) contribute meaningfully to circulating levels. The most consequential recent development in taurine research is Singh et al. (2023), published in Science, which reported that taurine levels decline substantially with age across species — including humans — and that taurine supplementation extended median lifespan by approximately 10–12% in middle-aged mice and improved multiple health span markers including bone density, muscle strength, energy expenditure, gut microbiome composition, immune function, and reduced cellular senescence. The paper also included preliminary non-human primate data with directionally consistent findings. This is high-impact work from a rigorous group and published in a top-tier journal. However, the critical caveat is that lifespan benefit in humans has not been established — the human data in the paper is cross-sectional (circulating taurine correlates with health markers), and the history of mouse longevity interventions translating to humans is mixed at best. Cardiovascular evidence is more developed. Epidemiological data — particularly from Japanese populations with high seafood and taurine intake — has associated higher taurine status with lower rates of cardiovascular mortality. Mechanistically, taurine modulates intracellular calcium signaling, reduces oxidative stress, and may attenuate vascular inflammation. Controlled trials have shown modest reductions in blood pressure and improvements in exercise tolerance in populations with cardiovascular disease, though large-scale RCTs in healthy adults are lacking. Exercise performance data is preliminary and mixed. Systematic review evidence (Kurtz et al., 2021) suggests taurine supplementation (1–6 g/day) may modestly reduce exercise-induced oxidative stress and markers of muscle damage, with some improvements in endurance performance. Effect sizes are generally small and study designs are heterogeneous. Taurine is widely considered safe at supplemental doses up to 3 g/day, and higher doses (up to 6 g/day) have been studied without serious adverse events. It is worth noting that taurine in energy drinks (typically 1–2 g per can) is often conflated with isolated taurine supplementation — the concerns around energy drinks largely relate to high caffeine content and combined stimulants, not taurine itself.
Read full evidence summary →Top studies
Taurine deficiency as a driver of aging
Circulating taurine levels decline significantly with age across multiple species including humans. Taurine supplementation extended median lifespan by approximately 10–12% in middle-aged mice and improved multiple health span markers (energy expenditure, bone density, muscle strength, gut microbiome composition, reduced cellular senescence). Effects in non-human primates were directionally consistent but the study was not powered for lifespan endpoints.
Taurine deficiency may contribute to biological aging; supplementation extended lifespan and improved health span in mice
Well-tolerated in animals at doses studied; human translation is uncertain
Lifespan evidence is animal-only (mice, worms); human data is cross-sectional only; causal relationship in humans not established; translation from mouse biology to human aging is uncertain
Taurine: a "very essential" amino acid
Taurine functions as an antioxidant, osmoregulator, and modulator of calcium homeostasis. Clinical and epidemiological data link higher taurine status to lower cardiovascular risk. Supplementation studies have shown modest blood pressure reduction and improvements in exercise tolerance in cardiovascular patients.
Taurine may support cardiovascular health through antioxidant and osmoregulatory mechanisms
Generally well-tolerated at doses studied; concern exists around energy drink consumption (combined with caffeine) rather than isolated taurine
Narrative review; confounding in observational cardiovascular data; many studies used disease populations
Expert Mentions
All 3 mentions"There was a really striking paper published in Science in 2023 showing that taurine levels decline substantially as we age — and this appears to be conserved across species. When they supplemented taurine in middle-aged mice, they saw meaningful extensions in lifespan and improvements across multiple health domains. It's one of the more exciting longevity findings in recent years, though we have to be careful about extrapolating mouse data to humans."
Taurine levels decline with age, and a landmark 2023 Science paper suggests that taurine deficiency may be a driver of aging — with supplementation extending lifespan in mice and improving multiple health span markers.
The claim accurately describes the Singh et al. 2023 Science paper findings. Taurine levels do decline with age in humans (cross-sectional data, n=12,775) and taurine supplementation did extend lifespan in mice (~10–12% increase in median lifespan) and worms. The caveat about mouse-to-human translation is appropriately included. The paper is well-designed and high-impact, but lifespan benefit in humans remains unestablished — the human translation is the critical unknown.
"The Singh et al. paper in Science is really important. We've known for a while that taurine has cardiovascular benefits, but the idea that it might be a driver of aging itself — that as our levels decline, this contributes to the aging phenotype — is a significant conceptual shift. And what's compelling is the data across multiple model organisms and the human cross-sectional correlation. That said, we're still missing the human interventional data."
The 2023 taurine-aging paper is one of the most significant longevity findings in recent years — taurine is not just a component in energy drinks, it's a molecule with broad roles in cardiovascular health, muscle function, and potentially in the pace of biological aging.
The characterization of taurine's cardiovascular evidence is grounded (Schaffer et al. 2012 review; epidemiological data from Japan linking high taurine intake to low cardiovascular mortality). The framing of the Singh et al. 2023 findings is accurate and appropriately flagged as requiring human interventional data before longevity claims can be made with confidence. The observation about energy drinks being a misleading framing of taurine is a fair scientific communication point.
Key findings
- ·Taurine levels decline with age in humans and multiple animal species (cross-sectional data, n=12,775 humans; Singh et al. 2023 Science).
- ·Taurine supplementation extended lifespan ~10–12% in middle-aged mice and improved multiple health span markers — a high-profile finding that does not yet have human lifespan replication.
- ·Epidemiological data links higher taurine intake to lower cardiovascular mortality; controlled trials show modest blood pressure reductions in cardiovascular populations.
Evidence gaps
- ·No human RCT evidence on longevity or lifespan outcomes; mouse data cannot be directly extrapolated.
- ·Large, well-powered cardiovascular RCTs in healthy adults are lacking.
- ·Optimal dose and duration for specific outcomes have not been established.